VX
Vasiliki Xirou
Credentials:
History
- 2023–2026
Residency
- 2019–2023
Medical School
Research
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
Laboratory Investigation · 2022 · 130 citations
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
Oncogene · 2019 · 68 citations
Cancer Research Communications · 2023 · 18 citations
- DR
6 papers
3 papers
- VY
3 papers
- JZ
2 papers
- KS
2 papers
- RH
2 papers
- AL
1 paper
1 paper
